Begin the claim process, contact us today

Have you taken any of following drugs? (check all that apply)

Have you suffered any of the following injuries? (check all that apply)

Do you smoke?


Yaz Injury
Attorneys at Law

Toll-free: (800) 626-7047

If you have been injured, call us today for an evaluation (800) 626-7047.

Latest Yaz News

Leading Brand of Birth Control Yaz Lawsuits Top 1,100

Tuesday, March 30th, 2010

Bayer’s Yaz problems continue to grow. The major pharmaceutical company’s 2009 annual report includes more than 1,100 lawsuits related to alleged life-threatening side effects of the popular prescription birth control medication known by the names Yaz, Yasmin and Ocella. More lawsuits are expected.

The current lawsuits, including five class action lawsuits—three in the U.S. and two in Canada—allege that Bayer marketed the contraceptive with full knowledge that the drug could cause serious side effects and even death. (more…)

Bookmark and Share

March Update for Yaz and Yasmin Birth Control

Friday, March 12th, 2010

Over 1,100 YAZ lawsuits are pending throughout the United States, located in three types of courts: Federal (all cases are being filed in Illinois), New Jersey and Pennsylvania.  Below is an update on these cases:

Federal YAZ Cases

The majority of the YAZ injury cases involving heart attacks, strokes, blood clots, gallbladder removal, and other injuries, are being filed in what is know as a multidistrict litigation (MDL); there are 891 cases on the docket.  These cases have been consolidated for “pretrial” discovery, which will include the review of  documents, emails, and other reports from Yaz’s maker, Bayer Pharmaceuticals.   If you are a resident of California, Texas, Washington, or any other state, if your Yaz lawsuit is a federal case it will be filed here.

At the March 4, 2010 status conference Judge Herndon confirmed that Bayer, the defendant, has produced over 10 million pages of documents in response to discovery requests.

Judge Herndon denied remain is some of the cases where the plaintiffs – the people filing the lawsuits against Bayer – sought to be in a state court for diversity grounds, most of which were adding pharmacists as defendants in the cases.  Hon. Herndon said that the diversity was not sufficient for the plaintiffs, and the cases will remain joined with the other federal cases.

New Jersey YAZ Cases

Assignment Judge Donald Volkert formally requested YAZ, Yasmin and Ocella to be consolidated in New Jersey state courts on November 10, 2009.   Chief Justice Stuart Rabner ordered that all pending and future state actions regarding YAZ, Yasmin or Ocella would be designated as “mass torts.”   A mass tort is a civil lawsuit that involves numerous plaintiffs, and they can take place in both federal and state courts.

An initial conference is set for April 26, 2010. The Judge has filed an order regarding initial management of the cases. Click here to visit the court’s website

Pennsylvania YAZ Cases

YAZ and Yasmin cases is the Court of Common Pleas in Philadelphia, Pennsylvania. These cases are before Judge Sandra Mazer Moss, and have been officially designated as a “mass tort.”

Bookmark and Share

Indiana women sue makers of Yaz birth control

Tuesday, February 23rd, 2010

Recently, a group of 39 women from Indiana filed a lawsuit against the makers of Yaz, a popular oral contraceptive, claiming that the birth control pill caused them to suffer severe side effects.

These Yaz lawsuits, submitted to the US Federal Court in Indianapolis in early February 2010, are the latest in a flood of claims being filed against Bayer Pharmaceuticals, the drug company that manufactures and markets birth control pills Yaz and Yasmin.

A majority of the women involved in the most recent Yaz lawsuit have required removal of their gallbladders as a result of serious Yaz related side effects.  (more…)

Bookmark and Share

Deep Vein Thrombosis an Injury linked to Yaz usage

Friday, December 18th, 2009

Numerous recent reports have shined the light on some serious risks associated with Yaz birth control. When this pill first came on the market, many women were led to believe that this oral contraceptive presented unique benefits that other pills did not offer. Thanks to an aggressive ad campaign run by Yaz manufacturer Bayer pharmaceuticals, many women switched to or began taking Yaz without (more…)

Bookmark and Share

Pulmonary embolisms linked to Yaz birth control

Thursday, December 17th, 2009

A few major medical studies have recently indicated a clear link between use of the popular birth control pill Yaz and an increased risk of pulmonary embolism. Pulmonary embolism is a serious and life threatening cardiovascular injury. Though the risk of pulmonary embolism increases with the use of any oral contraceptive, studies show that Yaz presents a significantly higher risk of this serious injury, compared to other birth control pills.

Pulmonary Embolisms linked to yazWhat is Pulmonary Embolism?

Pulmonary embolism is a serious and life threatening medical emergency. This condition occurs when one or more of the lungs’ arteries become blocked. In most cases, these arteries become blocked by a blood clot that has traveled to the lungs from another part of the body, such as the legs or pelvis area. Signs and symptoms of pulmonary embolism, though different for each individual, often include sudden and unexplainable chest pain, shortness of breath, and a cough that may produce bloody sputum.

Many otherwise healthy young women taking Yaz have suffered pulmonary embolism as a result of taking this birth control pill. It is important to speak with a doctor if you are concerned about these risks or if you are experiencing any possible symptoms of pulmonary embolism while taking Yaz.

What have the recent studies found?

A study published in the British Medical Journal reports that women who use Yaz are more than six times more likely to suffer venous thrombosis, compared to women who do not use oral contraceptives. This risk was considerably higher for women using Yaz, compared to those taking other oral contraceptives. In fact, these researchers recommend using a safer alternative to Yaz, stating “our results clearly show that the safest option with regard to the risk of venous thrombosis is an oral contraceptive containing levonorgestrel combined with a low dose of estrogen.”

Another 2009 study published in the medical journal Contraception, explains why Yaz may increase the risk of pulmonary embolism and other cardiovascular injuries. This smaller study indicated that initiating use of Yaz, or other birth control pills with the same chemical combination of dropirenone (progrestone) and ethinylestradiol (estrogen), causes an increase in lipid peroxidation. This medical condition is linked with high serum copper levels in the body, a situation that increases the risk of cardiovascular injury. The results of these tests echo the results of oral contraceptive studies dating back to 1998, which also linked oral contraceptive use to these increased copper levels.

Current Research

While studies continue to examine the link between pulmonary embolism and Yaz oral contraceptive, it is clear that Yaz presents a higher risk of this serious cardiovascular injury compared to other oral contraceptives or non-use of such drugs. A study initiated this year involving over 80,000 American and European birth control pill users hopes to find more definitive answers about the link between Yaz and cardiovascular risks like pulmonary embolism.

Until then, patients and their doctors must carefully weigh the risks and benefits of taking Yaz with the information currently available.

If you or someone you know has suffered an injury from Yaz, Yasmin or Ocella, such as a pulmonary embolism, stroke, or other serious injury, contact our law firm to learn about you legal rights.  There is no cost for a consultation and no obligation.  We welcome your questions.

Bookmark and Share

Yaz’s link to Gallbladder Disease

Thursday, December 17th, 2009

Never before has our firm received so many intakes linking gall bladder disease and subsequent removal from the potential use of Yaz, Yasmin and Ocella. Recently, medical studies have shown a link between the use of popular birth control pill (Yaz) and the development of serious side effects including stroke, blood clots, and gallbladder problems. For those that have already had their gallbladder removed, they understand what its purpose is in the body and what they can expect now that they are without one. For the rest of you who do not have a full understanding of the gallbladder’s functions, including what gallstones are, the text below (more…)

Bookmark and Share

Study finds an increased risk of blood clot in Yaz users

Thursday, December 17th, 2009

Yaz—a popular new birth control pill marketed by Bayer Pharmaceutical—has received a lot of negative press in the last year or so—and with good reason. Recently, two major studies published in the British Medical Journal reported that Yaz, and its contraceptive cousins Yasmin and Ocella, significantly increase the risk of serious injury.

One British Medical Journal report, published in September 2009, found that Yaz increases the risk of blood clots in users. In fact, Yaz users are six to seven times (more…)

Bookmark and Share

Yaz Injuries and the Safety of 3rd Generation Contraceptives

Monday, November 30th, 2009

Yaz, Yasmine and Ocella have catapulted into the headlines lately for good reason. Yaz, was quickly launched in major ad campaigns back in 2006 (Yasmin was approved by the FDA in 2001) and touted as the answer to quality of life for women. Were these extravagant promises? Did the drug companies use enough due diligence when reviewing the complications and side effects of these medications before approving them for consumer use?

yaz-injury-ballonsWhile it is no secret that birth control pills have had adverse effects since they were first introduced in the early 1960’s, there is no other medication that has influenced the lives of women more than “the pill”.

Yaz and sister contraceptive Yasmin, both made by Bayer and their generic version Ocella sold by Teva Pharmaceuticals, once introduced and approved for pharmaceutical companies quickly became some of the most widely used “third generation” contraceptives.  Third generation contraceptives are best (more…)

Bookmark and Share

Yaz Incidents of Death and Injury in U.S. and Europe

Wednesday, November 18th, 2009

The oral contraceptives Yaz and Yasmin, made by Bayer, have recently come under fire internationally following allegations that they carry a higher risk of injury than other birth controls on the market.

Yaz and Yasmin both contain estrogen and a type of progestin called drospirenone. Interestingly enough, drospirenone is not found in other birth controls that are available in the United States. Drospirenone impacts the body’s normal mechanism of regulating a balance between salt and water. This results in elevated potassium levels, known as hyperkalemia, which is known to cause potentially life-threatening heart problems and other health issues. (more…)

Bookmark and Share

Yaz and Yasmin lawsuit update

Friday, November 13th, 2009

On the first of October 2009, an MDL, or multi-district litigation action, was established in the United States. This MDL is known as the “Yasmin and Yaz Marketing, Sales Practices, and Products Liability Litigation.” Judge David R. Herdon, from the Southern District of Illinois has been assigned to this MDL. An initial conference is scheduled for November 19, 2009.

So what does this mean? (more…)

Bookmark and Share